Natural gas remained the dominant source of U.S. electricity in the first half of 2026, generating 767 terawatt-hours, essentially flat compared with the same period last year. Wind and solar combined reached
More
New Jersey has significantly expanded worker protections under its Temporary Disability Insurance and Family Leave Insurance programmes, with new guidance now published by the state’s Department of Labor. The New Jersey Department
More
A provocative question posed by one man’s friend has sparked a wider debate about how Donald Trump’s record compares to any American who has ever lived. The argument began when a friend
More
For decades, legal contracts and product documentation occupied completely separate corners of any technology business relationship, rarely speaking to each other. If you needed to understand how software actually functioned, you consulted
More
Rolls-Royce Holdings (LSE: RR) has delivered extraordinary returns for shareholders over the past year and a half, cementing its reputation as one of the FTSE 100’s standout performers. Since the start of
More
Former US President Donald Trump threatened to impose a 50% tariff on Canadian-built automobiles, sending shockwaves through global auto markets and rattling investor confidence. The proposed tariff targets vehicles manufactured in Canada
More
Playtech (PTEC) topped the list of gainers in the FTSE 250 during a session that saw notable movement across the mid-cap index. The gaming technology company outperformed its peers, drawing attention from
More
The Confederation of British Industry has called on Chancellor John Healey to cut employer taxes ahead of the Autumn Budget to address Britain’s worsening youth unemployment crisis. In a report published Tuesday,
More
RFK Jr. Seeks Public Input On Childhood Vaccine Classification Framework After Trump Executive Order
Health and Human Services Secretary Robert F. Kennedy Jr. is pushing to overhaul how the United States develops and categorises its childhood vaccine recommendations. Kennedy posted a Request for Information on Friday,
More
Swedish drugmaker Hansa Biopharma is positioning itself for a potential US stock market listing as a critical regulatory verdict on its kidney transplant drug draws near. The company submitted draft forms to
More